SFE Investment Counsel lowered its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 57.0% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 582 shares of the medical equipment provider's stock after selling 772 shares during the quarter. SFE Investment Counsel's holdings in Intuitive Surgical were worth $304,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Other institutional investors also recently added to or reduced their stakes in the company. Massachusetts Financial Services Co. MA purchased a new position in shares of Intuitive Surgical in the third quarter worth about $558,807,000. International Assets Investment Management LLC raised its position in Intuitive Surgical by 49,383.6% during the third quarter. International Assets Investment Management LLC now owns 1,090,619 shares of the medical equipment provider's stock valued at $535,788,000 after acquiring an additional 1,088,415 shares in the last quarter. FMR LLC raised its position in Intuitive Surgical by 8.3% during the third quarter. FMR LLC now owns 10,971,085 shares of the medical equipment provider's stock valued at $5,389,765,000 after acquiring an additional 838,793 shares in the last quarter. Wilmington Savings Fund Society FSB raised its position in Intuitive Surgical by 15,322.2% during the third quarter. Wilmington Savings Fund Society FSB now owns 555,661 shares of the medical equipment provider's stock valued at $272,980,000 after acquiring an additional 552,058 shares in the last quarter. Finally, Strategic Financial Concepts LLC raised its position in Intuitive Surgical by 50,740.8% during the fourth quarter. Strategic Financial Concepts LLC now owns 312,671 shares of the medical equipment provider's stock valued at $163,202,000 after acquiring an additional 312,056 shares in the last quarter. Institutional investors own 83.64% of the company's stock.
Insider Activity
In other Intuitive Surgical news, Director Amal M. Johnson sold 4,635 shares of the company's stock in a transaction on Tuesday, January 28th. The stock was sold at an average price of $566.60, for a total value of $2,626,191.00. Following the transaction, the director now owns 12,275 shares of the company's stock, valued at approximately $6,955,015. This represents a 27.41 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, EVP Robert Desantis sold 376 shares of the company's stock in a transaction on Friday, November 29th. The shares were sold at an average price of $539.00, for a total value of $202,664.00. Following the completion of the transaction, the executive vice president now directly owns 5,506 shares in the company, valued at $2,967,734. This represents a 6.39 % decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 6,348 shares of company stock valued at $3,587,582. Insiders own 0.90% of the company's stock.
Intuitive Surgical Stock Performance
Shares of ISRG traded up $4.16 during mid-day trading on Friday, reaching $595.55. 1,188,781 shares of the company's stock traded hands, compared to its average volume of 1,979,754. The business's 50-day moving average price is $559.48 and its 200-day moving average price is $519.66. The stock has a market capitalization of $212.12 billion, a P/E ratio of 92.91, a price-to-earnings-growth ratio of 5.67 and a beta of 1.39. Intuitive Surgical, Inc. has a 12 month low of $364.17 and a 12 month high of $616.00.
Analysts Set New Price Targets
ISRG has been the subject of several recent research reports. Bernstein Bank lifted their price target on Intuitive Surgical from $655.00 to $700.00 and gave the company an "overweight" rating in a research report on Monday, January 27th. Royal Bank of Canada raised their price objective on Intuitive Surgical from $611.00 to $641.00 in a report on Monday, January 27th. Erste Group Bank raised Intuitive Surgical from a "hold" rating to a "buy" rating in a report on Tuesday, November 19th. Evercore ISI raised their price objective on Intuitive Surgical from $490.00 to $530.00 in a report on Monday, January 27th. Finally, Leerink Partners raised their price objective on Intuitive Surgical from $490.00 to $548.00 in a report on Monday, January 27th. One equities research analyst has rated the stock with a sell rating, five have given a hold rating and sixteen have assigned a buy rating to the company's stock. According to MarketBeat.com, the company has a consensus rating of "Moderate Buy" and a consensus target price of $613.10.
View Our Latest Stock Analysis on ISRG
About Intuitive Surgical
(
Free Report)
Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.
Featured Articles

Before you consider Intuitive Surgical, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Intuitive Surgical wasn't on the list.
While Intuitive Surgical currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.